BackInsight Molecular Diagnostics Overview

Insight Molecular Diagnostics Long Term Debt

Track Insight Molecular Diagnostics's long-term debt ($580K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$579000.00
↓ 62.13% YoYΔ $-950000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Insight Molecular Diagnostics Long Term Debt History

Loading

Insight Molecular Diagnostics vs. peers: Long Term Debt Comparison

Loading

Insight Molecular Diagnostics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Insight Molecular Diagnostics (IMDX) FAQ

The latest long-term debt for IMDX is $580K as of September 2026. That compares with $1.5M in the prior-year period — down 62.1% year over year. Investors often review this figure alongside Insight Molecular Diagnostics's historical trend and sector peers before judging valuation or financial health.

Over the past year, IMDX's long-term debt moved from $1.5M to $580K — a 62.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Insight Molecular Diagnostics's operating scale or balance-sheet position.

A long-term debt figure of $580K for IMDX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IMDX's long-term debt ($580K), review year-over-year change from $1.5M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Insight Molecular Diagnostics's long-term debt against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.

Questions & Answers